Consensus Core Laboratories Inc. Deutsche Boerse AG

Stocks

HJ1

US21867A1051

Business Support Services

Market Closed - Deutsche Boerse AG Other stock markets 05:45:15 27/06/26 am AEST			5-day change	1st Jan Change
9.350 ^EUR	+5.65%		-5.56%	-31.25%

30/04	Core Laboratories Inc., Q1 2026 Earnings Call, Apr 30, 2026
30/04	Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M	MT

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

cbff6c3fc1828c007c1.Mva7qrp0O8MryCORMyTEJNG0g9IzzFOkEDdcH50jxYA.W5vDnPEjae5AjFn3R3aGdabGyotelWGWZ3MJa6hRhOlcpP3Y2zUL9VqHZg~3f3d8161fda60b87d3616a5d9422980f

Analysts' recommendations: Core Laboratories Inc.

12/03/25	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
07/03/25	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/10/24	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/10/24	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/07/24	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
30/01/24	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/09/23	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
01/08/23	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/06/23	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
02/05/23	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
02/05/23	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
29/04/23	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
19/04/23	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
08/02/23	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
10/01/23	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
08/10/22	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/09/22	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
03/08/22	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
02/08/22	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
16/07/22	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
14/07/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
14/07/22	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
03/05/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/04/22	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT
12/04/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
SGS SA			+5.84%
UL SOLUTIONS INC.			+10%
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.			+40.59%
EMTEK (SHENZHEN) CO., LTD.	-	-	-
TIC SOLUTIONS, INC.			+42.17%
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.	-	-	+79.79%
GRG METROLOGY & TEST GROUP CO., LTD.			+50.78%
Average			+38.19%
Weighted average by Cap.			+14.91%